Do you want to read an article? Please log in or register.
Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients
Hepatology
Related content
Hepatology
Patient-reported Outcomes (PROs) in Patients with Non-alcoholic Fatty Liver Disease: A Narrative Review of CLDQ-NAFLD/NASH
J Gastroenterol Hepatol.
Yamamura S, Nakano D, Hashida R, Tsutsumi T, Kawaguchi T, Okada M, Isoda H, Takahashi H, Matsuse H, Eguchi Y, Sumida Y, Nakajima A, Gerber L, Younossi ZM, Torimura T
doi: 10.1111/jgh.15172.
Hepatology
Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis
Metabolism.
Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G
doi: 10.1016/j.metabol.
Hepatology
Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies
Hepatol Res.
Parohan M, Yaghoubi S, Seraj A
doi: 10.1111/hepr.13510.
Further Publications
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
J Hepatol
Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A
doi: 10.1016/j.jhep.2021.07.035
HepatitisHepatology
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis
Lancet Gastroenterol Hepatol.
Nguyen-Khac E, Thiele M, Voican C, Nahon P, Moreno C, Boursier J, Mueller S, de Ledinghen V, Stärkel P, Gyune Kim S, Fernandez M, Madsen B, Naveau S, Krag A, Perlemuter G, Ziol M, Chatelain D, Diouf M
doi: 10.1016/S2468-1253
Hepatology
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
No abstract available
COMMENTED
Inflammatory Bowel Disease
Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology.
Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD
doi: 10.1053/j.gastro.2020.05.032.
Hepatology
Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study
J Clin Med.
van den Berg EH, Gruppen EG, Blokzijl H, Bakker SJL, Dullaart RPF
doi: 10.3390/jcm8122157.
Hepatology
Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study
Clin Gastroenterol Hepatol.
Baratta F, Pastori D, Angelico F, Balla A, Paganini AM, Cocomello N, Ferro D, Violi F, Sanyal AJ, Del Ben M
doi: 10.1016/j.cgh.2019.12.026.